The manufacturer of the prescription medication Pradaxa(r) is voluntarily recalling all patient-level lots of 75mg dosage of the medication.
The reason is a potential packaging defect that the manufacturer says may compromise the integrity of the bottle and permit moisture to enter and impair the effective dose.
If you have the 75 mg. dose of Pradaxa (r), you should contact your Medco/Express Scripts pharmacy for further instructions on return/replacement.
Medco customers who have been prescribed that medication by their physicians also will be receiving a letter from Medco/Express Scripts.
Related News
- SMART-TD statement on the results of the U.S. Senate vote to impose the rail agreement
- SMART-TD statement on potential extension of status-quo period
- SMART-TD statement on congressional intervention in the national rail negotiations
- ERMA lifetime maximum benefit to increase in 2023
- RRB: Credit for military service under the Railroad Retirement Act
- 2022 Tentative Agreement ratification results and next steps
- Split decision: Unions for engineers and conductors take different routes in freight rail contract ratification vote
- Balloting closes TONIGHT for tentative national rail agreement
- SMART-TD, BLET town hall yields facts about tentative agreement
- A message to veterans from President Ferguson